论文部分内容阅读
目的探析采用康复新液治疗反流性食管炎的临床疗效。方法于2014年3月-2015年3月,随机选取该院门诊治疗的40例反流性食管炎患者作为研究对象,分为对照组(n=20例)和观察组(n=20例),对照组患者进行常规(莫沙必利、奥美拉唑)治疗,观察组患者在对照组基础上采用康复新液治疗,对比治疗效果以及不良反应发生情况。结果经内镜检查,两组患者的临床症状均有所改善,观察组治疗总有效率高于对照组,两组患者的不良反应发生率对比,差异有统计学意义(P<0.05)。结论对反流性食管炎患者采用康复新液治疗,临床效果显著,值得推广。
Objective To investigate the clinical effect of Kangfuxinye on reflux esophagitis. Methods From March 2014 to March 2015, 40 patients with reflux esophagitis were selected randomly as control group (n = 20) and observation group (n = 20) The patients in the control group were treated with conventional (mosapride and omeprazole). The patients in the observation group were treated with Kangfuxin solution on the basis of the control group, and the treatment effect and the incidence of adverse reactions were compared. Results The endoscopic examination showed that the clinical symptoms of both groups were improved. The total effective rate of observation group was higher than that of control group. There was significant difference between the two groups in the incidence of adverse reactions (P <0.05). Conclusion The treatment of reflux esophagitis patients with rehabilitation of new liquid, the clinical effect is significant, it is worth promoting.